NovaBay collaborates with ImprimisRx to promote prescription Avenova

NovaBay Pharmaceutical Inc., a clinical-stage biopharmaceutical company focusing on commercializing of Avenova for the eye care market, has reportedly announced a partnership with ImprimisRx, one of the leading ophthalmology-focused pharmaceutical companies promoting prescription Avenova.

Under this partnership, ImprimisRx, a solely owned subsidiary of Harrow Health, Inc., will provide NovaBay with national sales, marketing, and distribution support for its FDA-cleared 0.01 percent hypochlorous acid Avenova in 40 ml bottles.

Avenova is an antibacterial lid and lashes solution that has been clinically proven to help manage various chronic eye problems.

Justin Hall, President and CEO of NovaBay Pharmaceuticals, said ImprimisRx had proven success in commercializing high-quality goods through its nationwide client base of thousands of ophthalmologists and optometrists, making it a perfect partner for expanding Avenova's reach.

ImprimisRx has expedited the ordering and delivery of medications by eliminating many levels in the traditional pharmaceutical value chain, said Mr. Hall, adding that under the recent collaboration with ImprimisRx, NovaBay can now cost-effectively increase Avenova's reach within the prescription channel by effectively interacting with optometrists and ophthalmologists, making prescription Avenova even more approachable than before.

Commenting on the collaboration, John Saharek, President of ImprimisRx, stated that Avenova is a remarkable addition to their firm’s growing ophthalmic product line. As the only lash and lid spray clinically verified to address the original cause of bacterial dry eye, Avenova complements its long-standing goal to offer customers quick and easy access to high-quality breakthrough medicines.

Avenova targets a vast and constantly rising dry eye market, with 30 million Americans suffering from blepharitis and meibomian gland dysfunction, among other chronic eye disorders. It's the only lid, and lashes spray with NovaBay's proprietary pure hypochlorous acid, and it's mild and gentle enough to use every day.

Avenova is commonly prescribed by optometrists and ophthalmologists before and after cataract and Lasik surgeries, making it a complementing treatment for many of ImprimisRx's other medications.

Source Credit - https://www.businesswire.com/news/home/20210719005026/en/NovaBay-Pharmaceuticals-Partners-with-Harrow-Health%E2%80%99s-ImprimisRx%C2%AE-to-Promote-Prescription-Avenova